Skip to main content

Federal Agency Roles in Cancer Drug Development from Preclinical Research to New Drug Approval The National Cancer Institute and the Food and Drug Administration (2005) / Chapter Skim
Currently Skimming:

Acronyms and Abbreviations
Pages 61-61

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 61...
... drug PDUFA Prescription Drug User Fee Act of 1992 PhRMA Pharmaceutical Research and Manufacturers of America PLA Product License Application RAID Rapid Access to Intervention Development Program RAMEM Radiation Modifier Evaluation Module Program RAND Rapid Access to NCI Discovery Resources Program RFA Request for Applications RNA Ribonucleic Acid SAGE Serial Analysis of Gene Expression SPORE Specialized Program of Research Excellence TTP Time to progression 61
Read the entire page →

Key Terms

  • research excellence
  • ribonucleic acid
  • module program
  • intervention development
  • nci discovery

  • pharmaceutical research
  • program ramem
  • drug pdufa
  • america pla
  • applications rna

  • prescription drug
  • product license
  • excellence ttp
  • license application
  • phrma pharmaceutical

  • evaluation module
  • resources program
  • discovery resources
  • pdufa prescription
  • application raid

  • program rand
  • acid sage
  • program rfa
  • fee act
  • expression spore

  • radiation modifier
  • serial analysis
  • drug user
  • modifier evaluation
  • user fee


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.